Czechia, July 23 -- Czechia based ROCHE s.r.o. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Drug supplies - RITUXIMAB 2026 . The value of the contract is worth 3684000 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....